GLS-5300

· GeneOne Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS-5300, covering 2020-05-27 to 2020-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers [Phase 1, Phase 2]